Understanding and Managing Corticosteroid-Induced Osteoporosis
Alexandra O Kobza,1 Deena Herman,1 Alexandra Papaioannou,2,3 Arthur N Lau,1 Jonathan D Adachi1 1Division of Rheumatology, Department of Medicine, McMaster University, Hamilton, ON, Canada; 2Division of Geriatric Medicine, Department of Medicine, McMaster University, Hamilton, ON, Canada; 3Department...
Guardado en:
Autores principales: | Kobza AO, Herman D, Papaioannou A, Lau AN, Adachi JD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f27234f7507349aa9ed3e103807626a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment of osteoporosis with teriparatide: The Slovenian experience
por: Kocjan Tomaz, et al.
Publicado: (2021) -
Bone Quality and Fractures in Women With Osteoporosis Treated With Bisphosphonates for 1 to 14 Years
por: Hartmut H Malluche, et al.
Publicado: (2021) -
Comparative assessment of fracture risk among osteoporosis and osteopenia patients: a cross-sectional study
por: Tomasevic-Todorovic S, et al.
Publicado: (2018) -
Treatment of osteoporotic fractures in alkaptonuria by teriparatide stimulates bone formation and decreases fracture rate – A report of two cases
por: L.R. Ranganath, et al.
Publicado: (2021) -
Impact of assessment of bone status before corrective surgery of lumbar spine in patients over 50 years old
por: Banse C, et al.
Publicado: (2019)